MIMS Must Have's
A review of some of the most important safety related changes, new indications and formulations changes we have made to the MIMS Product Information this month.

Click on below to access: 

• Important New Products
  • Bydureon
  • Clobex
  • Forxiga
  • Imojev
  • Menitorix
  • Nicorette 16hr Invisipatch
• New Indications
• Safety-Related Changes
• Full Update Medications
  (click to read the Full Prescribing Update)

Latest News

myDr
Diarrhoea - common causes...more

Heel spurs...more

Unsaturated fats...more

Fever...more

Consumer health and medical news and information from MIMS. Providing quality Australian patient information you can trust. myDr.com.au

Medical Observer
Call for action on combating antibiotic resistance...more

Dabigatran PBS listing expected...more

E-script software needs debugging...more

Codeine ban in children considered...more

For regular medical news, features and lifestyle content sign-up to receive Medical Observer’s e-newsletter at: medicalobserver.com.au

From the Desk of the Managing Editor

Which strength for which ingredient?

In recent months, many warnings have been issued regarding the potential for error when prescribing or dispensing products containing multiple active ingredients. This comes about due to the listing of active ingredients in alphabetical order, which could cause confusion and potentially increase the risk of error...more